Subscribe to Search results

A further update was provided to the team by Dr Jecock regarding the proposal to do away with discretionary payments, among other things.

Published on:

In an email from Morven Smith, he wrote on behalf of Baroness Primarolo asking those for proposals for options of dealing with Lord Archer's recommendations.

Published on:

Liz Woodeson had sent a response to Baroness Primarolo that addressed Lord Archer's recommendations with options.

Published on:

Morven Smith commented on Liz Woodeson's options to Baroness Primarolo with a comment that "These responses to recommendations seem much more robust and better incorporate your preferences." Baroness Primarolo later wrote "agreed" on the document.

Published on:

In oral evidence to the Infected Blood Inquiry, Dr Jecock discussed the options to increase annual payments had been based on what was affordable and no assessment of need.

Published on:

It had been confirmed in an email from Dr Jecock to Morven Smith that Dr Jecock had explained the difficulties that the report by Lord Archer had created for the Health Bill.

Published on:

Jenny Willott MP asked a parliamentary question on the timetable and mechanism for responding to the Archer report recommendations and Dawn Primarolo replied that they were receiving careful consideration and there would be a response in due course.

Published on:

A briefing pack was prepared for a debate which was to be held in the House of Lords on a motion proposed by Lord Morris to call attention to the findings of the Archer Inquiry.

Published on:

A debate was held in the House of Lords on a motion proposed by Lord Morris to call attention to the findings of the Archer Inquiry.

Published on:

Lord Morris moved his amendment to the Health Bill during its report stage.

Published on:

Lord Morris agreed to withdraw his amendment upon Lord Ara Darzi's undertaking to do everything possible to ensure that the Government responded fully to Lord Archer's recommendations before the Whitsun recess.

Published on:

Dr Gunson advised all regional transfusion centre directors that no blood products should be issued from repeatedly ELISA-positive donations.

Published on:

At an ACVSB meeting it was again agreed that surrogate screening should not be introduced before the results of the multi-centre study were available.

Published on:

Professor Tedder raised a concern that ELISA-positive but RIBA-negative samples might contain the virus.

Published on:

Dr Rejman wrote to Dr Gunson regarding steps to be taken regarding Hepatitis C testing in advance of the next ACVSB meeting.

Published on:

Dr Contreras wrote to colleagues at the North London Blood Transfusion Centre and Dr Gunson to protest that the proposed procedure for supplementary testing counselling and referral was "extremely complicated and astronomically expensive."

Published on:

The Working Group on Plasma Fractions met and noted that "Evidence of the value of the Chiron test for non-A non-B hepatitis is not yet available in this country. Future developments will be watched with much interest."

Published on:

Virologists Drs Mortimer, Tedder, Follett and others met to agree proposed arrangements to be put in place for confirmatory testing at three reference laboratories.

Published on:

Dr Gunson's proposals for pilot studies in Birmingham, Sheffield and Brentwood to the NHS Procurement Directorate were agreed and the studies took place over a two-week period in early December.

Published on:

Dr Gunson wrote to RTC directors in England and Wales informing them the Department of Health had agreed that routine anti-HCV testing could be put into operation.

Published on: